What is the activity of REVELIVIE PHARMA?

REVELIVIE PHARMA (SIREN 892023656) operates in the field of Autres intermédiaires du commerce en produits divers (NAF code 46.19B). This company was registered on 11/20/2020 and its registered office is located at 18 Rue Des Bruyères 56620 Pont-Scorff. You can view all legal notices related to this company on its dedicated page.

What is the legal form of REVELIVIE PHARMA?

REVELIVIE PHARMA is a company with the legal form 5710. Registered in the national register under the SIREN number 892023656, it was created on 11/20/2020. Find all legal information and BODACC notices concerning this company on BODACC.io.

Is REVELIVIE PHARMA still in operation?

REVELIVIE PHARMA is an active company. It is currently continuing its commercial operations. Its SIREN number is 892023656 and its registered office is located at 18 Rue Des Bruyères 56620 Pont-Scorff. Find its recent legal notices on BODACC.io.

Where is the registered office of REVELIVIE PHARMA located?

The registered office of REVELIVIE PHARMA is located at 18 Rue Des Bruyères 56620 Pont-Scorff. This company, registered under SIREN 892023656, was created on 11/20/2020 and operates in the field of Autres intermédiaires du commerce en produits divers.

Which BODACC notices concern REVELIVIE PHARMA?

4 recent BODACC notice(s) concern REVELIVIE PHARMA (SIREN 892023656). They cover the company's legal events: registration, modification, cessation of activity, or filing of accounts. Consult them to follow the company's evolution.

Does REVELIVIE PHARMA have an official website?

No official website has been identified for REVELIVIE PHARMA (SIREN 892023656). The company's legal information remains available on BODACC.io, the reference for civil and commercial announcements.

REVELIVIE PHARMA

SIREN 892023656

Active

What the register says about REVELIVIE PHARMA

REVELIVIE PHARMA is registered under SIREN number 892023656. Its registered office is located at 18 Rue Des Bruyères, 56620 Pont-Scorff. The company was founded on 20/11/2020. It declares that it operates in the Autres intermédiaires du commerce en produits divers sector. It is currently listed as active in the national business register.

BODACC has published 4 notices concerning it, the most recent dated 04/12/2025. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

Identity : REVELIVIE PHARMA

REVELIVIE PHARMA

SIREN: 892023656
Head office SIRET: 89202365600010
Legal form: SAS (société par actions simplifiée)
NAF code: 46.19B · Autres intermédiaires du commerce en produits divers
Address: 18 Rue Des Bruyères, 56620 Pont-Scorff
Creation date: 11/20/2020
Category: PME
Status: Active
VAT: FR60892023656
Filing: 12/04/2025
Closing: 12/31/2024

Recent notices (4)

12/04/2025Account depositsRÉVÉLIVIE PHARMA(principal)
12/19/2024Account depositsRÉVÉLIVIE PHARMA(principal)
07/06/2023Account depositsRÉVÉLIVIE PHARMA(principal)
11/11/2022Account depositsRÉVÉLIVIE PHARMA(principal)

All legal notices

Web presence : REVELIVIE PHARMA

The company's official website, its networks and online contact details.

Recent notices : REVELIVIE PHARMA

The BODACC notices published for this company.

RÉVÉLIVIE PHARMA

dpc · 12/04/2025

View

RÉVÉLIVIE PHARMA

dpc · 12/19/2024

View

RÉVÉLIVIE PHARMA

dpc · 07/06/2023

View

RÉVÉLIVIE PHARMA

dpc · 11/11/2022

View

Relations : REVELIVIE PHARMA

The relationship graph: linked notices, people and companies.

Public contracts : REVELIVIE PHARMA

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : REVELIVIE PHARMA

Frequently asked questions and the company's filing history.

Frequently asked questions : REVELIVIE PHARMA

Deposit filing history

4 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 12/31/2024.